Pharmaceutical Nanotechnology
The fascinating, quickly developing field of medical research known as "pharmaceutical nanotechnology" focuses on using nano scale materials for drug delivery and/or diagnostic purposes. Nanoparticles for chemotherapy-based TB treatment. The modified release behaviour of the anti-TB drugs loaded nanoparticles after oral administration was the cause of their increased efficacy. Three important drugs rifampin, isoniazid, and pyrazinamide were combined in PLG-nanoparticles.
Related Conference of Pharmaceutical Nanotechnology
November 24-25, 2025
7th World Congress on Advanced Clinical Trials and Clinical Research
Barcelona, Spain
November 24-25, 2025
4th International Forum on Pharmacovigilance and Regulatory Affairs
Barcelona, Spain
February 04-05, 2026
30th International Conference on Neuropharmacology and Neurochemistry
Bali, Indonesia
Pharmaceutical Nanotechnology Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D
Related Journals
Are you interested in
- Adaptive Trial Models - Clinical Trials Congress 2025 (Spain)
- Advanced Data Analytics - Clinical Trials Congress 2025 (Spain)
- Adverse Event Reporting through Mobile Health Tools - Euro Pharmacovigilance 2025 (Spain)
- AI in Clinical Research - Clinical Trials Congress 2025 (Spain)
- AI-Driven Signal Detection and Data Mining - Euro Pharmacovigilance 2025 (Spain)
- AI-Powered Pharmacovigilance - Clinical Trials Congress 2025 (Spain)
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2026 (Indonesia)
- Automation in Case Processing and Reporting - Euro Pharmacovigilance 2025 (Spain)
- Blockchain Applications - Clinical Trials Congress 2025 (Spain)
- Blockchain Applications in Regulatory Data Integrity - Euro Pharmacovigilance 2025 (Spain)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2026 (Indonesia)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2026 (Indonesia)
- Clinical Supply Chain Innovation - Clinical Trials Congress 2025 (Spain)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Data Integrity & Compliance - Clinical Trials Congress 2025 (Spain)
- Decentralized Trials - Clinical Trials Congress 2025 (Spain)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2026 (Indonesia)
- Digital Therapeutics Trials - Clinical Trials Congress 2025 (Spain)
- Digital Transformation in Drug Safety Operations - Euro Pharmacovigilance 2025 (Spain)
- Diversity in Enrollment - Clinical Trials Congress 2025 (Spain)
- eConsent & Retention Tools - Clinical Trials Congress 2025 (Spain)
- eSource & EDC Systems - Clinical Trials Congress 2025 (Spain)
- Ethics and Legal Challenges in Drug Safety Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Global Harmonization of Regulatory Frameworks - Euro Pharmacovigilance 2025 (Spain)
- Global Regulatory Landscape - Clinical Trials Congress 2025 (Spain)
- Global Signal Management Systems and Standards - Euro Pharmacovigilance 2025 (Spain)
- Inspection Readiness and Audit Best Practices - Euro Pharmacovigilance 2025 (Spain)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2026 (Indonesia)
- Integration of PV with Quality and Regulatory Affairs - Euro Pharmacovigilance 2025 (Spain)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2026 (Indonesia)
- Managing Safety Data in Multi-Region Submissions - Euro Pharmacovigilance 2025 (Spain)
- Master Protocol Strategies - Clinical Trials Congress 2025 (Spain)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2026 (Indonesia)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2026 (Indonesia)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2026 (Indonesia)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2026 (Indonesia)
- Patient-Centric Designs - Clinical Trials Congress 2025 (Spain)
- Patient-Centric Pharmacovigilance Strategies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Compliance in Clinical Trials - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Accelerated Drug Approvals - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance in Gene and Cell Therapies - Euro Pharmacovigilance 2025 (Spain)
- Pharmacovigilance Outsourcing and Vendor Oversight - Euro Pharmacovigilance 2025 (Spain)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2026 (Indonesia)
- Real-World Evidence in Post-Marketing Surveillance - Euro Pharmacovigilance 2025 (Spain)
- Real-World Evidence Integration - Clinical Trials Congress 2025 (Spain)
- Risk Management Planning and Benefit-Risk Assessment - Euro Pharmacovigilance 2025 (Spain)
- Risk-Based Monitoring - Clinical Trials Congress 2025 (Spain)
- Safety Labeling Changes and Regulatory Communication - Euro Pharmacovigilance 2025 (Spain)
- Safety Monitoring of Biologics and Biosimilars - Euro Pharmacovigilance 2025 (Spain)
- Synthetic Control Arms - Clinical Trials Congress 2025 (Spain)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Virtual Trial Platforms - Clinical Trials Congress 2025 (Spain)
- Wearables & Remote Monitoring - Clinical Trials Congress 2025 (Spain)